PICILLO, Marina
 Distribuzione geografica
Continente #
NA - Nord America 4.945
EU - Europa 1.416
AS - Asia 746
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 7.116
Nazione #
US - Stati Uniti d'America 4.933
CN - Cina 422
IT - Italia 406
UA - Ucraina 320
IE - Irlanda 206
DE - Germania 157
VN - Vietnam 145
TR - Turchia 144
SE - Svezia 137
RU - Federazione Russa 61
FI - Finlandia 53
IN - India 26
GB - Regno Unito 24
CZ - Repubblica Ceca 16
FR - Francia 12
CA - Canada 9
JP - Giappone 6
PL - Polonia 5
EU - Europa 4
AU - Australia 3
BE - Belgio 3
ES - Italia 3
LU - Lussemburgo 3
GR - Grecia 2
IL - Israele 2
MX - Messico 2
NL - Olanda 2
NO - Norvegia 2
BR - Brasile 1
CH - Svizzera 1
DK - Danimarca 1
HK - Hong Kong 1
HR - Croazia 1
MA - Marocco 1
MD - Moldavia 1
PA - Panama 1
Totale 7.116
Città #
Ann Arbor 1.168
Princeton 612
Chandler 520
Wilmington 467
Jacksonville 408
Houston 290
Dublin 206
Ashburn 185
Woodbridge 180
Dong Ket 144
Izmir 142
Andover 117
Nanjing 109
Beijing 98
Boardman 82
Naples 79
Pellezzano 76
Salerno 64
Norwalk 62
Dearborn 46
Düsseldorf 46
Shenyang 43
Fairfield 37
Redwood City 37
West Jordan 35
Mestre 34
Changsha 32
Nanchang 32
Hebei 27
Pune 25
Jiaxing 20
San Diego 15
Tianjin 15
Los Angeles 14
Washington 13
Lecce 11
Brno 10
Rome 10
Seattle 10
Milan 9
Cambridge 8
Ottawa 7
Kunming 6
Fuzhou 5
Guangzhou 5
Jinan 5
Lappeenranta 5
Napoli 5
Orange 5
Perugia 5
Santa Maria A Vico 5
Assago 4
Dormagen 4
Munich 4
Brussels 3
Casoria 3
Frattamaggiore 3
Hefei 3
Helsinki 3
Marigliano 3
Menlo Park 3
Mercato San Severino 3
New York 3
Atella 2
Casavatore 2
Caserta 2
Chełmża 2
College Park 2
Dallas 2
Duncan 2
Eboli 2
Edinburgh 2
Freyburg 2
Fucecchio 2
Gaeta 2
Hangzhou 2
Madrid 2
Nagoya 2
Nocera Inferiore 2
Nürnberg 2
Oristano 2
Oslo 2
Redmond 2
Stockholm 2
Taizhou 2
Thessaloniki 2
Toronto 2
Vitry-le-François 2
Wenzhou 2
Wuhan 2
Albany 1
Amsterdam 1
Benatky nad Jizerou 1
Benevento 1
Bologna 1
Buffalo 1
Clapham 1
Copenhagen 1
Esslingen am Neckar 1
Falkenstein 1
Totale 5.694
Nome #
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 120
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 116
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 103
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 101
Increased bilirubin levels in de novo Parkinson's disease 98
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 97
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 95
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 82
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Sep;132(Pt 9):2350-5. PMID: 19584099 81
Gender and non motor fluctuations in Parkinson's disease: A prospective study 81
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 80
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 79
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 79
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 78
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 78
Quitting smoking: An early non-motor feature of Parkinson's disease? 77
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 77
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 77
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 77
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 76
PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family 74
The relevance of gender in Parkinson's disease: a review 73
Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale 73
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 72
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 72
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 71
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 71
Clinical progression of SYNJ1-related early onset atypical parkinsonism: 3-year follow up of the original Italian family 70
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 68
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 68
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 68
Uric acid relates to dopamine transporter availability in Parkinson's disease. 67
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 67
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 67
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 67
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 66
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 65
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 64
Evolution of mild cognitive impairment in Parkinson disease 64
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 64
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 63
Early MRI findings in acquired hepatocerebral degeneration. 63
Patients with Parkinson?s disease and scans with (predominant) ipsilateral dopaminergic deficit 63
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 62
Comment on Numao et al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy 62
Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards 62
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 61
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 60
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 59
Non-motor correlates of smoking habits in de novo Parkinson's disease 59
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 56
Subthreshold depression and subjective cognitive complaints in Parkinson's disease 56
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 55
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 55
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 55
Resting brain networks in patients with Parkinson's disease and freezing of gait 54
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 53
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 53
Progressive Parkinsonism, Balance Difficulties, and Supranuclear Gaze Palsy 52
Recent advances in Essential Tremor: Surgical treatment 52
Biomarkers of Parkinson's disease: recent insights, current challenges, and future prospects 52
Progression of striatal and extrastriatal degeneration in multiple systematrophy: a longitudinal diffusion-weighted MR study 51
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 51
Freezing of gait and executive functions in patients with Parkinson's disease. 50
Dopamine receptor agonists and depression in Parkinson's disease. 50
Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study 49
Comparative neuropsychological profile of pathological gambling, hypersexuality and compulsive eating in Parkinson’s disease. 48
Teaching NeuroImages: Pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 47
Medical Management of Parkinson's Disease after Initiation of Deep Brain Stimulation 45
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 45
Serum IGF-1 is associated with cognitive functions in early, drug-naive Parkinson's disease 44
Subdural continuous theta burst stimulation of the motor cortex in essential tremor 43
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 42
Establishing a Standard of Care for Deep Brain Stimulation Centers in Canada 41
When shaking during standing points to hereditary spastic paraplegias 41
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 41
The use of smell identification test in Parkinson's disease in Italy: Preliminary data 41
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 41
Hepatitis C virus-related hepatic myelopathy after treatment with Sofosbuvir and Ribavirin: A case report 40
Loss of cutaneous large and small fibers in naive and l -dopa-treated PD patients 39
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 39
Deep Brain Stimulation Target Selection for Parkinson's Disease 38
Medical Management of Movement Disorders. 38
Neuropsychiatric disturbances in parkinsonian patients with and without freezing of gait 38
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 37
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 37
Diffusion-weighted imaging in multiple system atrophy: a comparison betweenclinical subtypes 37
Midbrain MRI assessments in progressive supranuclear palsy subtypes 36
Genetic Screening for the LRRK2 R1441C and G2019S Mutations in Parkinsonian Patients from Campania. 35
Programming Deep Brain Stimulation for Tremor and Dystonia: The Toronto Western Hospital Algorithms 35
Eligibility Criteria for Deep Brain Stimulation in Parkinson's Disease, Tremor, and Dystonia 35
Exploring risk factors for stuttering development in Parkinson disease after deep brain stimulation 35
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 35
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 34
The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease 33
Progressive Supranuclear Palsy-Like Phenotype in a GBA E326K Mutation Carrier 33
APP-Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes 33
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 33
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 32
Predictors of deep brain stimulation outcome in tremor patients 32
Totale 5.884
Categoria #
all - tutte 27.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.168


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019208 0 0 0 0 0 0 0 0 0 0 192 16
2019/2020938 289 44 106 12 42 25 71 15 60 72 177 25
2020/2021733 8 51 57 4 106 64 90 5 72 5 84 187
2021/2022956 11 3 6 12 11 4 18 34 132 117 138 470
2022/20231.387 183 95 70 109 180 309 16 125 189 9 72 30
2023/2024693 52 116 44 65 34 113 42 83 61 78 5 0
Totale 7.564